0001214659-21-003636.txt : 20210330
0001214659-21-003636.hdr.sgml : 20210330
20210330174156
ACCESSION NUMBER: 0001214659-21-003636
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210326
FILED AS OF DATE: 20210330
DATE AS OF CHANGE: 20210330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharp Shalini
CENTRAL INDEX KEY: 0001377202
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 21788651
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-52136.xml
PRIMARY DOCUMENT
X0306
4
2021-03-26
0001576263
Mirati Therapeutics, Inc.
MRTX
0001377202
Sharp Shalini
C/O MIRATI THERAPEUTICS
9393 TOWN CENTRE DR. SUITE 200
SAN DIEGO
CA
92121
true
false
false
false
Common Stock
2021-03-26
4
A
false
2424
0.00
A
2424
D
Non Qualified Stock Option (right to buy)
164.98
2021-03-26
4
A
false
3523
0
A
2031-03-25
Common Stock
3523
3523
D
Grant of Restricted Stock Units (RSUs). Shares will vest 1/3rd annually on the anniversary of the grant date.
The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-inFact
2021-03-30